DehydraTECH-liraglutide is showing apparent superiority to DehydraTECH-semaglutide Select DehydraTECH-CBD formulations are showing apparent superiority to DehydraTECH-GLP-1 at 4 and 8 weeks KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX) & (NASDAQ:LEXXW)… Read More
Companies with a proven commitment to sustainability see benefits in revenue, profit, share price, brand reputation, and talent attraction Collaboration with stakeholders and suppliers identified as key requirement to accelerating… Read More
VANCOUVER, BC – Augurex Life Sciences Corp. announced that it will be presenting a scientific poster at the upcoming Spondylo Congress, taking place in Ghent, Belgium, from September 5th to… Read More
High bioavailability of INM-901 oral formulation provides similar drug concentration levels in the brain as intraperitoneal (IP) injection VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM),… Read More
VANCOUVER, BC – WEX Pharmaceuticals Inc. (“WEX” or the “Company”), a clinical-stage biotechnology company developing Halneuron® (Tetrodotoxin for Injection) for pain, is pleased to announce the filing of a U.S…. Read More
